Sign In
Buy HCAT
$1.33
-0.0200 (-1.48%)
At Close: Jun 03, 2026
Health Catalyst (HCAT) Reports Q1 Loss, Tops Revenue Estimates
07:32pm, Thursday, 06'th May 2021
Health Catalyst (HCAT) delivered earnings and revenue surprises of 53.85% and 3.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
7 Tech Stocks Becoming Healthcare Stocks
11:34am, Thursday, 01'st Apr 2021
Covid-19 has meant many tech stocks now put more resources in healthcare. These technology shares deserve to be on your radar.
Health Catalyst's Dan Burton Named a Utah Business CEO of the Year
08:30am, Wednesday, 31'st Mar 2021
SALT LAKE CITY, March 31, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst") (NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Health Catalyst Launches New Healthcare.AI™ to Deliver Augmented Intelligence at Scale to Healthcare Industry
09:00am, Wednesday, 10'th Mar 2021
SALT LAKE CITY, March 10, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
HCAT Stock Price: $54 Target (Up From $50) By Piper Sandler
08:15pm, Saturday, 06'th Mar 2021
The shares of Health Catalyst Inc (NASDAQ: HCAT) have received a price target increase from $50 to $54 by Piper Sandler. These are the details.
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call Transcript
09:10pm, Sunday, 28'th Feb 2021
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call Transcript
Health Catalyst to Participate in Upcoming Investor Conferences
08:00am, Friday, 26'th Feb 2021
SOUTH JORDAN, Utah, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati
Recap: Health Catalyst Q4 Earnings
04:56pm, Thursday, 25'th Feb 2021
Shares of Health Catalyst (NASDAQ:HCAT) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 23.81% year over year to ($0.16), which
Health Catalyst Reports Fourth Quarter and Year End 2020 Results
04:03pm, Thursday, 25'th Feb 2021
SOUTH JORDAN, Utah, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati
SALT LAKE CITY, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Health Catalyst Leader Appointed to Primary Care and Chronic Illness Standing Committee
06:05am, Monday, 11'th Jan 2021
SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod
Health Catalyst to Participate in Upcoming Investor Conference
04:10pm, Tuesday, 22'nd Dec 2020
SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Health Catalyst: Growth At The Intersection Of Health And Data
02:00am, Tuesday, 15'th Dec 2020
US healthcare costs have ballooned in recent years, yet at least 25% of that spending is due to general inefficiency. Health Catalyst provides a way for healthcare organizations to manage their data a
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript
11:09pm, Tuesday, 10'th Nov 2020
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript
Health Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates
05:25pm, Tuesday, 10'th Nov 2020
Health Catalyst (HCAT) delivered earnings and revenue surprises of 22.22% and 5.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
